These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
335 related articles for article (PubMed ID: 32793565)
21. Deepening a Simple Question: Can MSCs Be Used to Treat Cancer? Gomes JPA; Assoni AF; Pelatti M; Coatti G; Okamoto OK; Zatz M Anticancer Res; 2017 Sep; 37(9):4747-4758. PubMed ID: 28870893 [TBL] [Abstract][Full Text] [Related]
22. Mesenchymal Stromal/Stem Cells: A New Era in the Cell-Based Targeted Gene Therapy of Cancer. Marofi F; Vahedi G; Biglari A; Esmaeilzadeh A; Athari SS Front Immunol; 2017; 8():1770. PubMed ID: 29326689 [TBL] [Abstract][Full Text] [Related]
23. Nano-engineered mesenchymal stem cells as targeted therapeutic carriers. Sadhukha T; O'Brien TD; Prabha S J Control Release; 2014 Dec; 196():243-51. PubMed ID: 25456830 [TBL] [Abstract][Full Text] [Related]
24. Adipose tissue-derived stromal cells primed in vitro with paclitaxel acquire anti-tumor activity. Bonomi A; Coccè V; Cavicchini L; Sisto F; Dossena M; Balzarini P; Portolani N; Ciusani E; Parati E; Alessandri G; Pessina A Int J Immunopathol Pharmacol; 2013; 26(1 Suppl):33-41. PubMed ID: 24046947 [TBL] [Abstract][Full Text] [Related]
25. Mesenchymal stem cells as delivery vectors for anti-tumor therapy. Li Z; Fan D; Xiong D Stem Cell Investig; 2015; 2():6. PubMed ID: 27358874 [TBL] [Abstract][Full Text] [Related]
26. Mesenchymal stem cells in the osteosarcoma microenvironment: their biological properties, influence on tumor growth, and therapeutic implications. Zheng Y; Wang G; Chen R; Hua Y; Cai Z Stem Cell Res Ther; 2018 Jan; 9(1):22. PubMed ID: 29386041 [TBL] [Abstract][Full Text] [Related]
27. Mesenchymal stem cells with Sirt1 overexpression suppress breast tumor growth via chemokine-dependent natural killer cells recruitment. Yu Y; Liu Y; Zong C; Yu Q; Yang X; Liang L; Ye F; Nong L; Jia Y; Lu Y; Han Z Sci Rep; 2016 Oct; 6():35998. PubMed ID: 27782173 [TBL] [Abstract][Full Text] [Related]
28. Polylysine-modified polyethylenimine polymer can generate genetically engineered mesenchymal stem cells for combinational suicidal gene therapy in glioblastoma. Malik YS; Sheikh MA; Xing Z; Guo Z; Zhu X; Tian H; Chen X Acta Biomater; 2018 Oct; 80():144-153. PubMed ID: 30223091 [TBL] [Abstract][Full Text] [Related]
29. Tumor tropic delivery of doxorubicin-polymer conjugates using mesenchymal stem cells for glioma therapy. Zhang X; Yao S; Liu C; Jiang Y Biomaterials; 2015 Jan; 39():269-81. PubMed ID: 25468377 [TBL] [Abstract][Full Text] [Related]
30. Bone marrow-derived mesenchymal stem cells increase drug resistance in CD133-expressing gastric cancer cells by regulating the PI3K/AKT pathway. Ji N; Yu JW; Ni XC; Wu JG; Wang SL; Jiang BJ Tumour Biol; 2016 Nov; 37(11):14637-14651. PubMed ID: 27619680 [TBL] [Abstract][Full Text] [Related]
31. Doxorubicin has in vivo toxicological effects on ex vivo cultured mesenchymal stem cells. Oliveira MS; Carvalho JL; Campos AC; Gomes DA; de Goes AM; Melo MM Toxicol Lett; 2014 Jan; 224(3):380-6. PubMed ID: 24291741 [TBL] [Abstract][Full Text] [Related]
32. Erythropoietin-activated mesenchymal stem cells promote healing ulcers by improving microenvironment. Lu H; Wu X; Wang Z; Li L; Chen W; Yang M; Huo D; Zeng W; Zhu C J Surg Res; 2016 Oct; 205(2):464-473. PubMed ID: 27664897 [TBL] [Abstract][Full Text] [Related]
33. Involvement of Wnt/β-catenin signaling in the mesenchymal stem cells promote metastatic growth and chemoresistance of cholangiocarcinoma. Wang W; Zhong W; Yuan J; Yan C; Hu S; Tong Y; Mao Y; Hu T; Zhang B; Song G Oncotarget; 2015 Dec; 6(39):42276-89. PubMed ID: 26474277 [TBL] [Abstract][Full Text] [Related]
36. Cancer cell-soluble factors reprogram mesenchymal stromal cells to slow cycling, chemoresistant cells with a more stem-like state. El-Badawy A; Ghoneim MA; Gabr MM; Salah RA; Mohamed IK; Amer M; El-Badri N Stem Cell Res Ther; 2017 Nov; 8(1):254. PubMed ID: 29115987 [TBL] [Abstract][Full Text] [Related]
37. Mesenchymal stem cells as a novel carrier for targeted delivery of gene in cancer therapy based on nonviral transfection. Hu YL; Huang B; Zhang TY; Miao PH; Tang GP; Tabata Y; Gao JQ Mol Pharm; 2012 Sep; 9(9):2698-709. PubMed ID: 22862421 [TBL] [Abstract][Full Text] [Related]
38. A targeted nanoplatform co-delivering chemotherapeutic and antiangiogenic drugs as a tool to reverse multidrug resistance in breast cancer. Tian F; Dahmani FZ; Qiao J; Ni J; Xiong H; Liu T; Zhou J; Yao J Acta Biomater; 2018 Jul; 75():398-412. PubMed ID: 29874597 [TBL] [Abstract][Full Text] [Related]
39. Automated Large-Scale Production of Paclitaxel Loaded Mesenchymal Stromal Cells for Cell Therapy Applications. Lisini D; Nava S; Frigerio S; Pogliani S; Maronati G; Marcianti A; Coccè V; Bondiolotti G; Cavicchini L; Paino F; Petrella F; Alessandri G; Parati EA; Pessina A Pharmaceutics; 2020 Apr; 12(5):. PubMed ID: 32365861 [TBL] [Abstract][Full Text] [Related]
40. Mesenchymal stem cells and cancer: friends or enemies? Hong IS; Lee HY; Kang KS Mutat Res; 2014 Oct; 768():98-106. PubMed ID: 24512984 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]